NYSE - Nasdaq Real Time Price USD

CONMED Corporation (CNMD)

60.09
+1.04
+(1.76%)
As of 10:52:05 AM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Patrick J. Beyer President, CEO & Director 1.5M -- 1966
Mr. Todd W. Garner CPA Executive VP of Finance & CFO 1.04M -- 1969
Mr. Peter K. Shagory Executive Vice President of Strategy & Corporate Development 574.07k -- 1969
Mr. Curt R. Hartman Special Advisor 2.05M 703.8k 1964
Mr. Brent Lalomia Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, & Commercial Operations 542.38k -- 1976
Mr. Andrew Moller Principal Accounting Officer, VP & Corporate Controller -- -- 1975
Mr. Richard Glaze Chief Information Officer -- -- 1966
Ms. Hollie K. Foust Executive VP, General Counsel and Corporate Secretary -- -- 1975
Ms. Shanna L. Cotti-Osmanski Executive VP of Information Technology & CIO -- -- 1977
Mr. John Ferrell Executive Vice President of Human Resources -- -- 1968

CONMED Corporation

11311 Concept Boulevard
Largo, FL 33773-4908
United States
727 392 6464 https://www.conmed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
3,900

Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Corporate Governance

CONMED Corporation’s ISS Governance QualityScore as of June 1, 2025 is 2. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 3; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 13, 2025 at 12:00 AM UTC

Ex-Dividend Date

July 3, 2025 at 12:00 AM UTC

Dividend Date

July 29, 2025 at 10:59 AM UTC - August 4, 2025 at 12:00 PM UTC

CONMED Corporation Earnings Date

Recent Events

May 29, 2025 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 21, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 20, 2025 at 12:00 AM UTC

S-8 POS: Offering Registrations

May 6, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

May 1, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 30, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

April 1, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 25, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 18, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers